Guberina, M.; Pöttgen, C.; Guberina, N.; Hoffmann, C.; Wiesweg, M.; Richlitzki, C.; Metzenmacher, M.; Aigner, C.; Bölükbas, S.; Gauler, T.;
et al. Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease. Cancers 2024, 16, 1174.
https://doi.org/10.3390/cancers16061174
AMA Style
Guberina M, Pöttgen C, Guberina N, Hoffmann C, Wiesweg M, Richlitzki C, Metzenmacher M, Aigner C, Bölükbas S, Gauler T,
et al. Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease. Cancers. 2024; 16(6):1174.
https://doi.org/10.3390/cancers16061174
Chicago/Turabian Style
Guberina, Maja, Christoph Pöttgen, Nika Guberina, Christian Hoffmann, Marcel Wiesweg, Cedric Richlitzki, Martin Metzenmacher, Clemens Aigner, Servet Bölükbas, Thomas Gauler,
and et al. 2024. "Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease" Cancers 16, no. 6: 1174.
https://doi.org/10.3390/cancers16061174
APA Style
Guberina, M., Pöttgen, C., Guberina, N., Hoffmann, C., Wiesweg, M., Richlitzki, C., Metzenmacher, M., Aigner, C., Bölükbas, S., Gauler, T., Eberhardt, W. E. E., Forsting, M., Herrmann, K., Theegarten, D., Darwiche, K., Jendrossek, V., Stuschke, M., & Schuler, M.
(2024). Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease. Cancers, 16(6), 1174.
https://doi.org/10.3390/cancers16061174
